Biotech

All Articles

Sanofi's $80M bet on Fulcrum dystrophy medication finishes in phase 3 lose big

.Merely four months after Sanofi bet $80 million in upfront cash on Pivot Therapeutics' losmapimod, ...

Oncternal stock sinks 60% amidst discharges, test firings

.Cancer cells firm Oncternal Therapies is actually folding all its scientific trials and laying off ...

Roche is actually carrying out hopes that its own injectable excessive weight possibility might inevitably show 25% weight-loss in late-stage test

.Roche is actually keeping out hopes that its injectable obesity prospect could eventually demonstra...

Novo Nordisk hails 'exceptional' fat burning lead for dual-acting oral drug in very early trial

.Novo Nordisk has actually raised the top on a phase 1 trial of its dental amylin and also GLP-1 rec...

AbbVie sues BeiGene over blood stream cancer cells drug proprietary knowledge

.Only a few quick full weeks after winning an FDA Fast lane tag for its own investigational BTK degr...

Lilly delivers one-two punch with 2nd tranche of beneficial records on every week the hormone insulin prospect

.Soon after a good data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based firm is once mo...

BridgeBio reduces genetics treatment finances as clinical records disappoint

.BridgeBio Pharma is slashing its own genetics treatment finances and pulling back from the techniqu...

GSK relinquishes HSV injection really hopes after phase 2 fail, resigning race to Moderna, BioNTech

.GSK's attempt to build the very first vaccination for genital herpes simplex virus (HSV) has actual...

GSK's long-acting breathing problem medicine halved strikes in phase 3

.GSK's long-acting asthma procedure has been actually shown to cut in half the amount of assaults in...

AstraZeneca, Daiichi unload Dato-DXd's total survival fail

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually failed t...